NCT06491615View on ClinicalTrials.gov

National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

July 12, 2024

Primary Completion Date

June 27, 2054

Study Completion Date

June 27, 2054

Conditions
Inherited Ophthalmic DiseasesHypopigmentation DisorderCorneal DystrophyBlue-cone MonochromacyBest DiseaseAniridiaAlbinism
Trial Locations (2)

20892

RECRUITING

National Eye Institute (NEI), Bethesda

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH